{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:49:20Z","timestamp":1791524960114,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lana.2026.101576","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:48:20Z","timestamp":1784299700000},"page":"101576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Data-driven subclassification of type 2 diabetes in Mexico: a conceptual framework to improve diabetes care"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1843-3077","authenticated-orcid":false,"given":"Mario Cesar","family":"Torres-Ch\u00e1vez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaretzy","family":"Garc\u00eda-Manteca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Seiglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-937X","authenticated-orcid":false,"given":"Omar Yaxmehen","family":"Bello-Chavolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-1078","authenticated-orcid":false,"given":"Neftali Eduardo","family":"Antonio-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lana.2026.101576_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.lana.2026.101576_bib2","doi-asserted-by":"crossref","first-page":"s163","DOI":"10.21149\/14832","article-title":"Prevalencia de prediabetes y diabetes en M\u00e9xico: Ensanut 2022","volume":"65","author":"Basto-Abreu","year":"2023","journal-title":"Salud Publica Mex"},{"issue":"1","key":"10.1016\/j.lana.2026.101576_bib3","first-page":"30","article-title":"[Prevalencia de complicaciones de la diabetes y comorbilidades asociadas en medicina familiar del Instituto Mexicano del Seguro Social]","volume":"155","author":"Ovalle-Luna","year":"2019","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.lana.2026.101576_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-10-1","article-title":"Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey","volume":"10","author":"Reynoso-Nover\u00f3n","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1016\/j.lana.2026.101576_bib5","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s00125-020-05211-7","article-title":"The clinical consequences of heterogeneity within and between different diabetes types","volume":"63","author":"Redondo","year":"2020","journal-title":"Diabetologia"},{"issue":"1 Suppl 1","key":"10.1016\/j.lana.2026.101576_bib6","first-page":"S27","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.lana.2026.101576_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.lana.2026.101576_bib8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.lana.2026.101576_bib9","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa524","article-title":"Validation of the Swedish diabetes Re-Grouping scheme in adult-onset diabetes in China","volume":"105","author":"Li","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lana.2026.101576_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001506","article-title":"Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study","volume":"8","author":"Anjana","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"7","key":"10.1016\/j.lana.2026.101576_bib11","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3390\/jcm9072083","article-title":"Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: a Japanese retrospective cohort study","volume":"9","author":"Tanabe","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.lana.2026.101576_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.637945","article-title":"Novel reclassification of adult diabetes is useful to distinguish stages of \u03b2-Cell function linked to the risk of vascular complications: the DOLCE study from Northern Ukraine","volume":"12","author":"Fedotkina","year":"2021","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.lana.2026.101576_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00125-023-06082-4","article-title":"Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study","volume":"67","author":"Werkman","year":"2024","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.lana.2026.101576_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","article-title":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","volume":"7","author":"Dennis","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.lana.2026.101576_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000511362","article-title":"The association between antidiabetic agents and leukocyte telomere length in the novel classification of type 2 diabetes mellitus","volume":"67","author":"Huang","year":"2021","journal-title":"Gerontology"},{"issue":"7","key":"10.1016\/j.lana.2026.101576_bib16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/dc22-2170","article-title":"Potential value of identifying type 2 diabetes subgroups for guiding intensive treatment: a comparison of novel data-driven clustering with risk-driven subgroups","volume":"46","author":"Li","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lana.2026.101576_bib17","article-title":"Assessment of fatal cardiovascular disease risk using data-driven diabetes subgroups and SCORE2-Diabetes in 24,943 adults in Mexico City","author":"Perezalonso-Espinosa","year":"2025","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.lana.2026.101576_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s43856-023-00360-3","article-title":"Precision subclassification of type 2 diabetes: a systematic review","volume":"3","author":"Misra","year":"2023","journal-title":"Commun Med"},{"issue":"11","key":"10.1016\/j.lana.2026.101576_bib19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s00125-022-05769-4","article-title":"Phenotypic and genetic classification of diabetes","volume":"65","author":"Deutsch","year":"2022","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lana.2026.101576_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001550","article-title":"Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach","volume":"8","author":"Bello-Chavolla","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"10.1016\/j.lana.2026.101576_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes","volume":"178","author":"Bello-Chavolla","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.lana.2026.101576_bib22","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","article-title":"Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health","volume":"39","author":"Bello-Chavolla","year":"2020","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.lana.2026.101576_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1210\/clinem\/dgab762","article-title":"Prevalence trends of diabetes subgroups in the United States: a data-driven analysis spanning three decades from NHANES (1988-2018)","volume":"107","author":"Antonio-Villa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lana.2026.101576_bib24","article-title":"Diabetes subgroups and sociodemographic inequalities in Mexico: a cross-sectional analysis of nationally representative surveys from 2016 to 2022","volume":"33","author":"Antonio-Villa","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"5","key":"10.1016\/j.lana.2026.101576_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/dc20-2372","article-title":"Type 2 diabetes subgroups, risk for complications, and differential effects due to an intensive lifestyle intervention","volume":"44","author":"Bancks","year":"2021","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"10.1016\/j.lana.2026.101576_bib26","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc26-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.lana.2026.101576_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.eprac.2026.01.006","article-title":"American association of clinical endocrinology consensus statement: algorithm for management of adults with type 2 diabetes - 2026 update","volume":"32","author":"Samson","year":"2026","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.lana.2026.101576_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1057\/s41271-024-00470-9","article-title":"Segmentation and fragmentation of health systems and the quest for universal health coverage: conceptual clarifications from the Mexican case","volume":"45","author":"Becerril-Montekio","year":"2024","journal-title":"J Public Health Policy"},{"issue":"11","key":"10.1016\/j.lana.2026.101576_bib29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00125-022-05696-4","article-title":"Where to for precision treatment of HNF1A-MODY?","volume":"65","author":"Bonner","year":"2022","journal-title":"Diabetologia"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26002061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X26002061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:55:06Z","timestamp":1791521706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X26002061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S2667193X26002061"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2026.101576","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data-driven subclassification of type 2 diabetes in Mexico: a conceptual framework to improve diabetes care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2026.101576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101576"}}